Genesis Pharma S.A.

GENESIS Pharma, the leading Greek biopharmaceutical company, will participate in the BioSquare Conference 2005, one of the most important gatherings of the global life science community, to be held at the International Convention Centre of Lyon, France.

Ms. Aliki Kakolyri, Business Development Manager, will present the company's activities, vision and business goals during the session scheduled for April 15th at 9:00 a.m.

BioSquare will take place within the context of the World Life Sciences Forum, BioVision 2005.

Since its foundation in 1997, GENESIS Pharma -one of the fastest growing Greek pharmaceutical companies- has established itself as the premier marketer and distributor of biopharmaceutical products in Southeastern Europe and Cyprus. With its core business activity focusing on in-licensing, marketing, sales, and distribution of specialized pharmaceutical products stemming from biotechnology research, Genesis Pharma has forged powerful strategic alliances through exclusive agreements with leading American and European companies of cellular and molecular technology, such as Amgen, Biogen, Chiron, Cephalon, Shire, Vifor and Guilford Pharmaceuticals. The company has introduced and marketed an impressive portfolio of products in the region covering the fields of the Central Nervous System (CNS), Hematology / Oncology, Nephrology and Genetic disorders. Some products introduced by Genesis Pharma include Aranesp, Granulokine, Neulasta, Kineret, Avonex, Venofer, Modiodal and Tobi.

For more information please contact:

Aliki Kakolyri, Business Development Manager
GENESIS Pharma SA
24, Filellinon Street
Athens, GR-15232, Greece
Tel: +30 210 877 1500
Fax: +30 210 689 3877
e-mail: akakolyri@genesispharma.gr
Website: www.genesispharma.com.